|
Zhenping Zhu
Executive Vice President, Biologics President and CEO, Kadmon China
Kadmon Pharmaceuticals |
|
Prof.Patrick Baeuerle
Senior Vice President,
Chief Scientific Officer
Micromet |
|
Klaus Wilgenbus, M.D.
Corporate Senior Vice
President, Global BD& Licensing/Strategy
Boehringer Ingelheim |
|
Wei Zhang
Director General,
Department of Drug
Registration
State Food and Drug
Administration |
|
Dr.Jin-San Yoo,Ph.D.
President and CEO
PharmAbcine |
|
Mingde XIA, Ph.D.
Senior Director, COSAT
Johnson & Johnson |
|
Prof. Yajun Guo
President
Chinese Engineering Research Center for Antibody Medicine |
|
Kathleen Metters
Senior Vice President and Head of External Discovery and Preclinical Sciences
Merck Research Laboratories |
|
Oliver Zhang
Vice President, Antibody Drug Development
GenScript |
|
Roger Perlmutter Ph.D
Executive Vice President R&D
Amgen |
|
Prof.Zhinan Chen
Director, Cell Engineering Research Center, Department of Cell Biology
The Fourth Military Medical University |
|
Andrew Buchanan
Senior Team Leader and Scientist
MedImmune |
|
Jian Gao
Director of R&D Center
North China Pharmaceutical Group Corporation |
|
James Zhao
Partner
Vivo Ventures |
|
|
|
|